Xtant Medical Holdings' average one-year price target was raised 12.12% to $1.26 per share from $1.12. The revision is a positive analyst signal, but the article is limited to consensus target updates and does not include operational or financial results. Market impact should be modest.
Xtant Medical Holdings' average one-year price target was raised 12.12% to $1.26 per share from $1.12. The revision is a positive analyst signal, but the article is limited to consensus target updates and does not include operational or financial results. Market impact should be modest.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
